|
|
||||||||
|
FIGURE 3. Box plot showing net tumor-to-background ratio of 21 breast cancers in 21 women examined with 99mTc-exametazime and 99mTc-sestamibi. Wilcoxon matched-pairs test showed no significant difference between the 2 tracers (P = 0.82). HMPAO = exametazime; MIBI = sestamibi.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |